SIGA
SIGA Technologies, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
3.18
close · 2026-10-29
value
79
cheaper than peers79
quality
71
stronger fundamentals71
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 2.94× | 92 |
| price to book | 1.38× | 84 |
| price to sales | 4.20× | 34 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 0.3% | 99 |
| operating margin | 33.9% | 84 |
| return on equity | -1.5% | 57 |
| revenue growth | -49.5% | 7 |
4 of 4 measures available
Facts
| market cap | $228M |
| free cash flow | -$24.0M |
| employees | 49 |
| first trade | 1997-09-10 |
| next earnings | 2026-11-09 |
| fundamentals updated | 2026-08-31 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | 0.32 | 0.82 | 0.95 | 0.46 | not reported |
| free cash flow | $43.1M | $48.7M | $94.8M | $41.6M | not reported |
| net income | $23.3M | $59.2M | $68.1M | $33.9M | not reported |
| revenue | $94.6M | $138.7M | $139.9M | $110.8M | not reported |
| unusual items | not reported | not reported | not reported | $400,663 | $117,770 |